Government backs recommendations of NHS doctors-led AI Commission

The government has formally accepted all 44 recommendations made by the National Commission into the Regulation of AI in Healthcare, published on 10 September 2026, and outlined plans to deliver them across the UK. The response commits to developing a more agile, lifecycle-based regulatory framework for AI-enabled medical devices, ensuring patient safety and public trust while accelerating access to innovative technologies. The reforms aim to replace one-time assessments with continuous monitoring of AI devices throughout their operational life.

The MHRA has launched the third phase of its AI Airlock regulatory sandbox, which will focus on post-market surveillance and lifecycle regulation, directly aligning with the Commission’s recommendations. Applications are open to developers of eligible AI-enabled medical devices, with a webinar for prospective applicants scheduled for 22 October 2026. The first wave of innovators will be selected in November 2026, marking an immediate shift toward real-world monitoring of AI technologies.

Key commitments include issuing draft guidance by December 2026 on managing changes to AI-enabled devices as they evolve, and consulting in 2027 on classifying and qualifying these devices. The government also plans to explore staged authorisation pathways, allowing promising AI tools to be used in the NHS earlier under close supervision while gathering further evidence. A full implementation roadmap, detailing timelines and responsibilities, will be published by Spring 2027.

The government’s response emphasises strengthening patient engagement, improving access to redress for substandard care, and ensuring equitable benefits from AI across all communities. A new Programme Board will oversee progress across government, the MHRA, NHS partners, and devolved authorities, with regular updates planned to track delivery of the 44 recommendations.